NCT04943718View on ClinicalTrials.gov

Personalized Vaccine for Patients With Recurrent Malignant Glioma

PHASE1UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 15, 2021

Primary Completion Date

June 13, 2023

Study Completion Date

June 13, 2024

Conditions
Malignant GliomaRecurrent Glioma
Interventions
BIOLOGICAL

personalized vaccine

Based on genetic and transcriptional sequencing information, personalized peptide vaccines would be designed and produced; patients would be vaccinated on day 1, 4, 8 ,15, 22 and then on week 12, 20.

Trial Locations (1)

100054

RECRUITING

Xuanwu Hospital, Capital Medical University, Beijing

Sponsors
All Listed Sponsors
collaborator

Beijing Neoantigen Biotechnology Company

UNKNOWN

lead

Xuanwu Hospital, Beijing

OTHER